HDFC Mutual Fund Expands Stake in Global Health with ₹130 Crore Deal
HDFC Mutual Fund has significantly increased its footprint in the healthcare sector by acquiring an additional 10 lakh shares of Global Health, the operator of the renowned Medanta hospital chain. This latest transaction marks a continued strategic move by one of India's largest asset managers to deepen its holdings in high-growth healthcare enterprises.
Strategic Acquisition via Block Deal
In a significant open market transaction, HDFC Mutual Fund purchased 10 lakh shares of Global Health at an average price of ₹1,300 per share. The total value of this transaction amounts to ₹130 crore, representing a 0.37 per cent stake in the company. The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals.
This move follows a similar pattern of accumulation by the fund house; just last month, HDFC Mutual Fund had already purchased 10 lakh shares from Sachdeva for a value exceeding ₹122 crore. The consistent buying pattern suggests a strong institutional confidence in the long-term value proposition of the Medanta brand.
Impact on Founder Holding and Market Position
The sale of these shares by Sunil Sachdeva highlights a gradual reduction in the co-founder's direct equity holding. As of the end of the March quarter, Sachdeva held 2.90 crore equity shares, which equated to a 10.79 per cent stake in Global Health.
Despite the heavy institutional buying, the broader market reaction saw Global Health shares slip slightly by 0.41 per cent, closing at ₹1,311.35 apiece on the BSE. Such minor fluctuations are common during large-scale block deals as the market absorbs the change in shareholding patterns.
Strong Financial Performance Driving Investor Interest
The institutional interest in Global Health appears to be backed by robust fundamental growth. The company has demonstrated impressive financial momentum, particularly in its recent quarterly reporting. For the fourth quarter ended March 31, 2026, Global Health reported a substantial 39.7 per cent increase in Profit After Tax (PAT), reaching ₹141.7 crore compared to ₹101.4 crore in the same period of the previous fiscal year.
This bottom-line growth was supported by a significant surge in top-line performance. Revenue from operations for the quarter stood at ₹1,159 crore, marking a sharp climb from the ₹931.3 crore reported in the corresponding period of the previous year. This trajectory of increasing both revenue and profitability makes Global Health an attractive target for large-scale mutual fund portfolios seeking exposure to the expanding Indian healthcare market.
Key Takeaways
- Aggressive Accumulation: HDFC Mutual Fund has acquired a total of 20 lakh shares from co-founder Sunil Sachdeva over the last two months, with the latest deal valued at ₹130 crore.
- Robust Profitability: Global Health reported a nearly 40% year-on-year jump in PAT to ₹141.7 crore for the March 2026 quarter, driven by strong revenue growth.
- Institutional Confidence: The acquisition of a 0.37% stake through open market transactions underscores the institutional belief in Medanta's scalable healthcare model.